Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group

To the editor: DNA methyltransferase-inhibiting azanucleosides have become a mainstay of treatment of myeloid neoplasms in adult patients,[1][1] with 5-azacytidine (azacitidine) being the agent in broadest clinical use. Although not curative, treatment with azacitidine achieves hematologic

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cseh, Anna-Maria (VerfasserIn) , Kulozik, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 2 April 2015
In: Blood
Year: 2015, Jahrgang: 125, Heft: 14, Pages: 2311-2313
ISSN:1528-0020
DOI:10.1182/blood-2015-01-619734
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2015-01-619734
Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/125/14/2311
Volltext
Verfasserangaben:Annamaria Cseh, Charlotte M. Niemeyer, Ayami Yoshimi, Michael Dworzak, Henrik Hasle, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Ute Groß-Wieltsch, Andrea Candás, Andreas E. Kulozik, Lale Olcay, Meinolf Suttorp, Ingrid Furlan, Brigitte Strahm, Christian Flotho

MARC

LEADER 00000caa a2200000 c 4500
001 1560802138
003 DE-627
005 20220813194252.0
007 cr uuu---uuuuu
008 170713s2015 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2015-01-619734  |2 doi 
035 |a (DE-627)1560802138 
035 |a (DE-576)490802133 
035 |a (DE-599)BSZ490802133 
035 |a (OCoLC)1340977195 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cseh, Anna-Maria  |e VerfasserIn  |0 (DE-588)1136735674  |0 (DE-627)893515477  |0 (DE-576)490802109  |4 aut 
245 1 0 |a Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia  |b a retrospective analysis of the EWOG-MDS study group  |c Annamaria Cseh, Charlotte M. Niemeyer, Ayami Yoshimi, Michael Dworzak, Henrik Hasle, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Ute Groß-Wieltsch, Andrea Candás, Andreas E. Kulozik, Lale Olcay, Meinolf Suttorp, Ingrid Furlan, Brigitte Strahm, Christian Flotho 
264 1 |c 2 April 2015 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.07.2017 
520 |a To the editor: DNA methyltransferase-inhibiting azanucleosides have become a mainstay of treatment of myeloid neoplasms in adult patients,[1][1] with 5-azacytidine (azacitidine) being the agent in broadest clinical use. Although not curative, treatment with azacitidine achieves hematologic 
700 1 |a Kulozik, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1025736567  |0 (DE-627)723892032  |0 (DE-576)167091638  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 125(2015), 14, Seite 2311-2313  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia a retrospective analysis of the EWOG-MDS study group 
773 1 8 |g volume:125  |g year:2015  |g number:14  |g pages:2311-2313  |g extent:3  |a Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia a retrospective analysis of the EWOG-MDS study group 
856 4 0 |u http://dx.doi.org/10.1182/blood-2015-01-619734  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.bloodjournal.org/content/125/14/2311  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170713 
993 |a Editorial 
994 |a 2015 
998 |g 1025736567  |a Kulozik, Andreas  |m 1025736567:Kulozik, Andreas  |d 910000  |d 910500  |e 910000PK1025736567  |e 910500PK1025736567  |k 0/910000/  |k 1/910000/910500/  |p 12 
999 |a KXP-PPN1560802138  |e 2973929512 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 13.07.2017"],"relHost":[{"pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"titleAlt":[{"title":"Blood online"}],"part":{"year":"2015","issue":"14","pages":"2311-2313","volume":"125","text":"125(2015), 14, Seite 2311-2313","extent":"3"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"corporate":[{"display":"American Society of Hematology","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}],"disp":"Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia a retrospective analysis of the EWOG-MDS study groupBlood","recId":"266886647","origin":[{"dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]}}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"3 S."}],"title":[{"title_sort":"Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia","title":"Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia","subtitle":"a retrospective analysis of the EWOG-MDS study group"}],"person":[{"family":"Cseh","role":"aut","given":"Anna-Maria","display":"Cseh, Anna-Maria"},{"display":"Kulozik, Andreas","family":"Kulozik","role":"aut","given":"Andreas"}],"recId":"1560802138","name":{"displayForm":["Annamaria Cseh, Charlotte M. Niemeyer, Ayami Yoshimi, Michael Dworzak, Henrik Hasle, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Ute Groß-Wieltsch, Andrea Candás, Andreas E. Kulozik, Lale Olcay, Meinolf Suttorp, Ingrid Furlan, Brigitte Strahm, Christian Flotho"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2 April 2015"}],"id":{"eki":["1560802138"],"doi":["10.1182/blood-2015-01-619734"]}} 
SRT |a CSEHANNAMABRIDGINGTO2201